We are live on ! Find out more

1,405 hedge funds and large institutions have $41.4B invested in MetLife in 2024 Q4 according to their latest regulatory filings, with 188 funds opening new positions, 497 increasing their positions, 506 reducing their positions, and 76 closing their positions.

New
Increased
Maintained
Reduced
Closed

147% more first-time investments, than exits

New positions opened: 188 | Existing positions closed: 76

7% more funds holding

Funds holding: 1,3181,405 (+87)

0.19% more ownership

Funds ownership: 72.75%72.94% (+0.19%)

2% less capital invested

Capital invested by funds: $42B → $41.4B (-$659M)

2% less repeat investments, than reductions

Existing positions increased: 497 | Existing positions reduced: 506

14% less funds holding in top 10

Funds holding in top 10: 1412 (-2)

39% less call options, than puts

Call options by funds: $683M | Put options by funds: $1.12B

Holders
1,405
Holders Change
+87
Holders Change %
+6.6%
% of All Funds
18.47%
Holding in Top 10
12
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-14.29%
% of All Funds
0.16%
New
188
Increased
497
Reduced
506
Closed
76
Calls
$683M
Puts
$1.12B
Net Calls
-$441M
Net Calls Change
+$153M

MET Hedge Fund Activity: Q4 2024 in Review

1,405 of the 7,606 institutional investors tracked by Wall St. Rank reported a position in MetLife (MET) for Q4 2024, worth a combined $41.4B — down 1.6% from $42B a quarter earlier.

Buyers outnumbered sellers: 188 funds opened new MET positions and 76 closed out — a net gain of 112 holders — while 497 added to existing stakes and 506 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $517M. The largest seller was JP Morgan Chase, cutting an estimated $567M.

  • 1,405 institutional investors held MetLife (MET) as of Q4 2024, up from 1,318 in Q3 2024.
  • Funds reported $41.4B of MetLife stock for Q4 2024, down 1.6% quarter-over-quarter.
  • 188 funds opened new MetLife positions in Q4 2024 and 76 closed out, a net change of +112 holders.
  • The largest MetLife buyer in Q4 2024 was T. Rowe Price Associates, an estimated $517M added.
  • The largest MetLife seller in Q4 2024 was JP Morgan Chase, an estimated $567M sold.

Based on aggregated 13F filings for Q4 2024.